Undervalued by 14%, this wide-moat company has turnaround potential.

Danaher Corp (DHR) stock saw a modest uptick, ending the day at $244.11 which represents a slight increase of $5.75 or 2.41% from the prior close of $238.36. The stock opened at $239.61 and touched a ...

Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Check the time stamp on this data. Updated AI-Generated Signals for Danaher Corporation (DHR) available here: DHR. Type a few ...

ROCKVILLE, MD, UNITED STATES, January 23, 2025 /EINPresswire / -- The global cell culture media market is estimated at US$ 3.51 billion in 2024 and is projected to expand at a CAGR of 7.1% from 2024 ...

Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced its 2025 priorities and upcoming catalysts for ...

Porter Capital, a leader in specialty financing solutions for businesses nationwide, proudly announces the successful completion of a financing agreement for an international healthcare staffing ...

Thermo Fisher Scientific should be safe. RFK Jr. may disrupt Big Pharma, but he’s unlikely to cause research to completely ...

Understand the significant growth trajectory of the Electric Micromanipulators segment, which is expected to reach US$134.2 ...

Acacia has zero debt on the corporate level, but does have an accrued non-recurring legacy legal expense. Check out the ...

ImmunoPrecise has outperformed the broader market in a spectacular fashion. As of now, IPA’s YTD performance stands at +81.64%, a staggering increase compared to the S&P 500’s YTD performance of just ...